Immunotherapy for Recurrent Ependymomas in Children Using Tumor Antigen Peptides With Imiquimod

NCT01795313 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

23

Enrollment

OTHER

Sponsor class

Stopped Closed supratentorial arm prematurely secondary to lack of enrollment

Conditions

Ependymoma

Interventions

BIOLOGICAL: HLA-A2 restricted synthetic tumor antigen
DRUG: Imiquimod
OTHER: enzyme-linked immunosorbent assay
OTHER: flow cytometry
OTHER: immunohistochemistry staining method
OTHER: laboratory biomarker analysis

Sponsor

James Felker

Collaborators

[object Object]
[object Object]